Items where authors include "Dry, J.R."

Article

Hobor, S., Al Bakir, M. orcid.org/0000-0002-0846-8332, Hiley, C.T. et al. (292 more authors) (2024) Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling. Nature Communications, 15. 4871. ISSN 2041-1723

Wang, D. orcid.org/0000-0003-0068-1005, Hensman, J., Kutkaite, G. et al. (18 more authors) (2020) A statistical framework for assessing pharmacological responses and biomarkers using uncertainty estimates. eLife, 9. e60352. ISSN 2050-084X

Menden, M.P., Wang, D. orcid.org/0000-0003-0068-1005, Mason, M.J. et al. (19 more authors) (2019) Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen. Nature Communications, 10. 2674. ISSN 2041-1723

Delpuech, O., Rooney, C., Mooney, L. et al. (12 more authors) (2016) Identification of Pharmacodynamic Transcript Biomarkers in Response to FGFR Inhibition by AZD4547. Molecular Cancer Therapeutics, 15 (11). pp. 2802-2813. ISSN 1535-7163

Wappett, M., Dulak, A., Yang, Z.R. et al. (3 more authors) (2016) Multi-omic measurement of mutually exclusive loss-of-function enriches for candidate synthetic lethal gene pairs. BMC Genomics, 17. 65. ISSN 1471-2164

Bradford, J.R. orcid.org/0000-0002-7771-914X, Farren, M., Powell, S.J. et al. (10 more authors) (2013) RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib. PLoS ONE, 8 (6). e66003. ISSN 1932-6203